Cita APA

Bordonaro, R., Calvo, A., Auriemma, A., Rubovszky, G., Saunders, M. P., Argilés Martinez, G., . . . Hollebecque, A. (2021). Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: A dose-expansion, phase I study.

Citación estilo Chicago

Bordonaro, R., A. Calvo, A. Auriemma, G. Rubovszky, M. P. Saunders, Guillem Argilés Martinez, Josep Tabernero Caturla, y Antoine Hollebecque. Trifluridine/tipiracil in Combination With Oxaliplatin and Either Bevacizumab or Nivolumab in Metastatic Colorectal Cancer: A Dose-expansion, Phase I Study. 2021.

Cita MLA

Bordonaro, R., et al. Trifluridine/tipiracil in Combination With Oxaliplatin and Either Bevacizumab or Nivolumab in Metastatic Colorectal Cancer: A Dose-expansion, Phase I Study. 2021.